Tetra Bio-Pharma Inc.

10:01 AM EST - Tetra Bio-Pharma Inc. : Confirms its non-exclusive supply agreement for GMP-Grade THC with U.S.-based Rhodes Technologies Inc. The supply will be used for several drug development activities including Tetra’s cannabinoid-derived products PPP002, PPP003, and PPP004, as well as for discovery phase projects. This is additional to having a supply agreement with True North Cannabis Inc. for CBD from hemp which was necessary to meeting the demand associated with the Genacol Corporation transaction. Tetra Bio-Pharma Inc. shares V.TBP are trading up $0.04 at $0.95.